Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professors Irina Udalova and Paul Bowness have been selected to the British Society for Immunology (BSI) Congress Committee, starting in October 2016.

The BSI is the largest society in Europe and one of the oldest, largest, and most active immunology societies in the world. Its main objective is to promote and support excellence in research, scholarship and clinical practice in immunology for the benefit of human and animal health and welfare.

The committee is tasked with the planning and delivery of the BSI's Annual Congress, their flagship event which attracts over 1,000 delegates from around the world. The committee leads on drawing up the programme, selecting invited speakers and reviewing submitted abstracts as well as having responsibility for budget planning and overall conference organisation.

Professor Udalova said: "I am very pleased to join the BSI Congress committee. I thoroughly enjoyed shaping the Macrophage biology session for the BSI 2014 congress and felt I could contribute more to planning and delivery of future congresses. These congresses have been invaluable for exposing students and young scientists to the cutting edge questions in immunology and for fostering their interactions with peers throughout the UK."

"The British Society for Immunology (BSI) is now in its 60th year and remains at the forefront of education and discussion in the field of immunology, with its congress the flagship scientific and educational event. I am delighted to be given the opportunity to help shape this going forward." added Professor Bowness.

Both Professors Udalova and Bowness are due to attend their first meeting of the Congress Committee in October, joining the 16 member committee as their terms of office officially start.

Similar stories

Major ERC funding awarded to Professor Michael Dustin

Funding General

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.

Drug may boost vaccine responses in older adults

General Research

A preliminary study shows that a drug which helps immune cells self-clean may improve vaccine protection in older adults

£3M invested to drive forward early translation through five new Oxford-Bristol Myers Squibb Fellowships

Awards General

Five new Oxford-Bristol Myers Squibb Fellowships representing an investment of £3M have been announced. The fellowships (formerly Oxford-Celgene) will support postdoctoral researchers and clinicians across five departments within the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development.

Kennedy researcher receives MRC Clinical Training Fellowship

General

Dr Rahul Ravindran has been awarded a highly competitive MRC Clinical Research Training Fellowship, following a successful research placement at the Kennedy Institute in 2019.

Reach for the sky

General

A building project to extend the Kennedy Institute of Rheumatology building with a new floor will create much needed space for the Institute to expand, particularly in the areas of data science and clinical trials.

Researchers identify markers in joint fluid that could be the key to cartilage repair

General Research

Molecular changes in the joint fluid during surgical joint distraction reveal markers that may drive cartilage repair in osteoarthritis.